Navigation Links
Beaumont, U-M Open Study of Drug for Advanced Breast Cancer
Date:10/28/2009

receptors is found, making the existing treatments that target these receptors in other patients ineffective for TNBC patients. No treatment has been approved specifically for TNBC.

TNBC patients tend to be pre-menopausal; a large subgroup is African American. Many women with this cancer also have a BRCA-1 or BRCA-2 genetic mutation. TNBC is a fast-growing form of cancer with a higher risk of recurrence than other forms of breast cancer; average survival after recurrence is nine months.

"Based on recently reported clinical trials, the PARP inhibitors, including BSI-201, appear to be very beneficial and cause few side effects in patients with metastatic TNBC," says N. Lynn Henry, M.D., Ph.D., medical oncologist in the U-M Breast Oncology Program and principal investigator for this study at the University of Michigan. "It is exciting to be able to provide this new experimental treatment for our patients."

BSI 201 is seen as a significant breakthrough in the treatment of this aggressive cancer. A phase II study of the drug, reported at the May 2009 American Society of Clinical Oncologists annual meeting, found 62 percent of 116 patients who received the study drug with chemotherapy experienced a clinical benefit, compared to 22 percent who received only chemotherapy. Tumors shrank in 48 percent of women tested with BSI 201, compared with 16 percent on chemotherapy alone. The study found that the time till the cancer progressed for participants who received BSI 201 was a median of 6.9 months, compared to 3.3 months for women who received chemotherapy alone. Overall survival was 9.2 months with BSI 201 compared with 5.7 months for chemotherapy alone.
TNBC patients who may qualify for the study should call:

Beaumont Hospital, Cancer Clinical Trials at Royal Oak, 248-551-7695; Cancer Clin
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Let Kids Sleep Late on Weekends to Fight Fat: Study
2. NeoVista Presents Interim Study Results of Novel Therapy for the Treatment of Neovascular Age-Related Macular Degeneration
3. Old, New Pap Methods Equally Good, Dutch Study Finds
4. Stanford study recommends change in treating pulmonary embolisms
5. Deadly stomach infection rising in community settings, Mayo Clinic study finds
6. Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients
7. Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely
8. Wolves lose their predatory edge in mid-life, new U of Minnesota study shows
9. Study finds delay in follow-up among African-American women receiving abnormal breast finding
10. STAAR Surgical Collamer(R) Accommodating Study Team Reports First Phase Assessments at AAO
11. After Tonsillectomy, Short-Term Antibiotics Effective: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Beaumont, U-M Open Study of Drug for Advanced Breast Cancer 
(Date:8/27/2014)... August 28, 2014 The report provides ... (Laser designator, Laser Range Finder, LIDAR, 3D scanner, Laser ... Laser Doppler Vibrometer, Laser Altimeter) by Domain (Aerospace, Defense ... - 2020” published by MarketsandMarkets, and its application in ... The global Military Laser Systems market is expected to ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Spine Guide ... online source of information on spinal health. Now, the ... pain, or people suffering from back pain symptoms. Spine ... surgery, cervical/neck surgery, and lumbar spine surgery. , Some ... ache, shooting or stabbing pain, pain radiating down the ...
(Date:8/27/2014)... 27, 2014 DentistSave.com , ... has launched in the state of Tennessee to ... affordable dental care services at reduced rates. DentistSave.com ... consumers looking to save money on their dental ... a member of discount fee dental plan available ...
(Date:8/27/2014)... DC (PRWEB) August 28, 2014 The ... Betty Pierce Dennis, DrPH, MN, RN, FAAN, became the ... Center for the Advancement of the Science of Nursing ... of seven that comprise the NLN Home for Transformative ... nation’s capital a year ago. , Under Dr. ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 National ... participate in the Association for Medical Education in Europe ... in Milan, Italy August 30 – September 3, 2014. ... of the international medical education community, share the benefits ... to strengthen resident physician placement in countries throughout the ...
Breaking Medicine News(10 mins):Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2
... of transmission of senile amyloidosis to offspring from affected ... to child// have been raised. Details about the scientific ... AApoAII amyloidosis,' by Korenaga et al., can be cited ... Pathology. ,Dementia can result from several disease ...
... who wear seat belts show better chances of recovery even ... ,The research has revealed that of the 24,000 car accident ... three times more likely to die in the hospital than ... and his colleagues at the Medical College of Wisconsin in ...
... College London have found that by boosting up the levels of ... reduced appetite and higher activity levels, with the only side effect ... what tells our brains whether we're full after a meal, but ... this hormone than those who do not put on weight. They ...
... of Obstetrics and Gynecology has advocated the use of ... relief// after a cesarean section. The researchers say that ... morphine. ,Using these drugs for pain relief ... undesirable side effects such as nausea and drowsiness for ...
... motor neurone disease can be reduced by around 60 percent, ... or vitamin E, according to a new study. ,In ... in vegetable oils such as corn oil and omega 3 ... ,The motor neurone diseases (MND) are a group of progressive ...
... a portable water filtration system, powered by bicycle that ... Technological University's (NTU) institute of environmental science and engineering ... a mechanical pump and a membrane module to filter ... first, NTU experts said it is an improvement on ...
Cached Medicine News:Health News:Doubts About In UteroTransmission Of Senile Amyloidosis 2Health News:A New Study Shows That A Hormone Could Lead To Weight Loss 2Health News:Polyunsaturated Fat, Vitamin E Lowers Risk Of Motor Neurone Disease 2
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... DANVERS, Mass. , Aug. 27, 2014 North ... with a prestigious R&D 100 Award for the new OSRAM ... laser and LED-based white light module for microscopy, endoscopy and ... Xenon lamps with significantly higher efficacy and lamp life. ... as one of the most innovative new technologies of ...
(Date:8/27/2014)... Aug. 27, 2014 Amgen (NASDAQ: ... Administration (FDA) has granted priority review designation for ivabradine ... is an oral drug that inhibits the I ... node, the body,s cardiac pacemaker. 1 Ivabradine works ... myocardial contractility or ventricular repolarization. 1 Heart failure ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... First U.S. Clinical Data on XIENCE V ... Follow-Up,Results from the ABSORB Bioabsorbable Stent Clinical ... /PRNewswire-FirstCall/ --,Abbott will present data from several ... during a number of late-breaking,clinical trial and ...
... La Jolla,Pharmaceutical Company today announced updated interim antibody,reduction ... (abetimus,sodium), its drug candidate for systemic lupus erythematosus,("lupus" ... that there is a definitive and significant dose ... mg doses of Riquent compared,with placebo (p=0.0001). These ...
Cached Medicine Technology:Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 2Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 3Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 4Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6
... Most practitioners consider the HOPE nebulizer the ... have been made to put everything together in ... The result is our #11320 Adult HOPE Kit ... corrugated tubing and pediatric aerosol mask all in ...
... medication nebulizers offer a spill-proof design and ... a 45° angle. All medical nebulizers are ... variety of configurations are available., ,All ... ,Portex® medication nebulizers feature consistently fine ...
... delivery of medication as well as humidification, ... closed dilution, high volume, continuous medication nebulizer ... to patients. Its 200 ml reservoir and ... 8 hours of nebulized medication delivery at ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
Medicine Products: